With annual deaths from malaria on the rise: Scientists ask 'where is all the money going?'April 14, 2008New study questions use of millions of dollars dedicated to malaria prevention A new study in the April issue of the American Journal of Tropical Medicine and Hygiene, asks the question "With more than $220 million dollars dedicated to malaria treatment and prevention, why is the annual mortality rate from malaria on the rise" The study, entitled "Malaria Vector Management: Where Have We Come From and Where Are we Headed"" conducted by researchers from the University of Alabama at Birmingham School of Medicine, examines the current methods used to control and prevent the spread of malaria. Robert J. Novak, Ph.D., professor of medicine, division of infectious diseases and Ephantus J. Muturi, Ph.D., postdoctoral fellow, division of infectious diseases, who lead the study, say the millions of dollars currently being spent on malaria primarily address the mortality of pregnant women and infants. And, while these efforts are important and have resulted in successfully decreasing the death rate in that group with the use of bed nets and insecticides, the disease has burgeoned among teens and adults who are not being protected. Dr. Muturi, a native of Kenya, who himself has been stricken by malaria, finds the lack of immediate attention frustrating on a more personal level. "I have family in Kenya who are at risk every day. Bed nets work at night and have helped contain the spread of malaria, but what about the hours when people aren't in their beds" The protection during the day is minimal with current insecticides that cannot be used on a regular basis. The search for a vaccine is necessary, but so are the immediate needs of at-risk communities." The scientists say that organizations such as the Bill & Melinda Gates Foundation and The World Health Organization's Roll Back Malaria, lead in funding research for drug and vaccine development and to provide bed nets, but little of this funding is directed to help identify and address environmental factors that contribute to the growth and spread of this fatal disease. "We need to address three issues - vectors, parasites, and protect the human host, in an integrated fashion" says Dr. Novak. He explains that by working with environmental and epidemiological information that is already available, researchers can determine where malaria mosquito populations are most concentrated and then design a control program with the right preventive methods. "We can quickly access information by working with the Integrated Malaria Management Consortium. But, funding is needed to know where, when and how to apply the current tools that we have to be most effective with disease prevention. And, to properly educate the at-risk populations so they can better protect themselves." Some of the tools that Dr. Novak refers to include modifying the environmental sources proven to house malaria mosquitoes; using environmentally friendly insecticides; determining the exact sections of marsh land, rivers and rice paddies that contain mosquito larvae, and only treating those areas during breeding times to more effectively manage the mosquito population. Identifying these "hot spots" is not only more environmentally friendly, but is also cost effective. "Relying on drugs and bed nets is the same mentality as in the 1960s and we know that thinking didn't work since malaria is still here stronger than ever, so we need to attack the disease in new and more efficient methods," says Dr. Novak. "By properly combining past successful tactics in managing malaria with new technology in insecticides, surveillance, GIS/remote satellite, PCR and new drugs, malaria can become a minor disease." American Society of Tropical Medicine and Hygiene |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. Media availability: The role of biomedical research in malaria eradication Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year. Ineffective monotherapies common in high-burden malarious countries ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk. New tool promises more accurate antimalarial drug dosing Scientists at LSTM have developed a tool to support the development of appropriate age-based dosing regimens for malaria drugs. Cell phones become handheld tools for global development Mobile phones are on the verge of becoming powerful tools to collect data on many issues, ranging from global health to the environment. Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||